Patent · US Active

Compounds

US8153623B2 · kind B2 · utility

9Cited by
3References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 4, 2010
Grant dateApr 10, 2012
Priority date—
Expiry dateAug 4, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D487/10
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds of formula (I), pharmaceutical compositions thereof, and methods for treatment using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.